购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • AChR
    (1)
  • Others
    (5)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (1)
  • 6-8周
    (4)
  • 3-6月
    (1)
抑制剂&激动剂
细分筛选
搜索结果
TargetMol产品目录中 "tm 10"的结果
筛选
搜索结果
TargetMol产品目录中 "

tm 10

"的结果
  • 抑制剂&激动剂
    6
    TargetMol | Inhibitors_Agonists
  • BuChE-IN-TM-10
    TM-10
    T106302313524-95-5
    BuChE-IN-TM-10 (TM-10) 是一种有效的丁基胆碱酯酶 (BuChE) 抑制剂,其IC50 值为8.9 nM。BuChE inhibitor 1能够抑制和分解自诱导的Aβ聚合, 表现出强大的抗氧化活性和良好的血脑屏障 (BBB) 渗透性。可用于阿尔兹海默症的研究。
    • ¥ 1290
    In stock
    规格
    数量
  • Btm 1042
    Btm1042,Btm-1042
    T2382972293-40-4
    Btm 1042 is an antispasmodic drug. It has been found to depress twitch responses in the ileum of guinea pigs.
    • ¥ 10600
    6-8周
    规格
    数量
  • BTM-1086
    T1000872293-17-5In house
    BTM-1086 is a potent gastric secretory inhibitor and an anti-ulcer agent.
    • ¥ 10600
    3-6月
    规格
    数量
  • GT-2227
    T70112186096-20-8
    GT-2227 is a histamine H3 receptor antagonist.
    • ¥ 10600
    6-8周
    规格
    数量
  • ATM-1001
    T701131860819-82-4
    ATM-1001 is an inhibitor of the cancer-associated tropomyosin 3.1 (Tpm3.1), suppressing glucose-stimulated insulin secretion (GSIS) from the pancreatic islets.
    • ¥ 10600
    6-8周
    规格
    数量
  • NU1085
    T71908188106-83-4
    NU1085 is a potent poly(ADP-ribose) polymerase (PARP) inhibitors have been developed that potentiate the cytotoxicity of ionizing radiation and anticancer drugs. The biological effects of NU1085 [Ki = 6 nM], in combination with temozolomide (TM) or topotecan (TP) have been studied in 12 human tumor cell lines (lung, colon, ovary, and breast cancer). Cells were treated with increasing concentrations of TM or TP + - NU1085 (10 microM) for 72 h.
    • ¥ 10600
    6-8周
    规格
    数量